+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Dried Blood Spot Collection Cards Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • ID: 5119925
  • Report
  • January 2022
  • Region: Global
  • 117 Pages
  • Mordor Intelligence

FEATURED COMPANIES

  • Ahlstrom-Munksjö
  • ARCHIMEDlife
  • CENTOGENE N.V
  • F. Hoffmann-La Roche Ltd
  • PerkinElmer
  • QIAGEN

The Dried Blood Spot (DBS) Collection Cards Market is expected to register a CAGR of 3% during the forecast period. This is attributing to the increasing use of DBS cards in diagnostic testing, the rise of forensic toxicology applications. In addition, the increasing use of dried blood spot collection cards in newborn screening for the detection of metabolic disorders in newborn babies is expected to trigger the growth of the market. Several benefits associated with Dried blood spot collection cards such as ease of use, easy to store, and early and effective diagnosis compared to conventional alternatives result in promoting the growth of the market. In addition, these DBS cards are used in several more clinical applications such as therapeutic drug monitoring, HIV surveillance, and clinical chemistry applications. As per Centers for Diseases Control and Prevention, in 2018 approximately 37,832 individuals were diagnosed with HIV in the United States. Thus growing usage of DBS technology in autoimmune diseases for diagnosis and testing results in propelling the overall market in the future.



Key Market Trends


Dried blood spot collection cards in newborn screening are estimated to witness healthy growth in the future


Dried blood spot (DBS) collection cards in newborn screening are estimated to witness healthy growth in the future attributed to an increasing number of newborn babies and growing demand for newborn screening. As per UNICEF, in 2018 around 2.5 million babies died in the first month of life due to lack of proper screening. Thus, due to surge in the demand for screening and to prevent these deaths in the future, there is a need for proper screening. DBS is widely used for screening in newborn babes and several benefits associated with them make it highly preferable. Benefits are short diagnostic period, low cost, easy collection & storage, minimally invasive procedure, high precision, and many more.



In addition, with the increasing incidences of HIV is also fueling market growth. Several players had launched technologically advanced cards for HIV testing and diagnosis. Some of them are Cobas Plasma Separation Cards launched by Roche.



North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period


North America is expected to hold a significant market share in the global Dried Blood Spot Collection Cards Market due to the high demand for newborn screening, the increasing number of newborn babies, rising prevalence of HIV diseases. Moreover, technological advancements, the presence of several major players, increasing R&D expenditure, rising healthcare expenditure, and the presence of well-established healthcare infrastructure is also fueling the growth of the overall regional market to a large extent.



Competitive Landscape


The Dried Blood Spot Collection Cards Market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are F. Hoffmann-La Roche Ltd, QIAGEN, Shimadzu Scientific Instruments, Eastern Business Forms, Inc, Ahlstrom-Munksjö , PerkinElmer, ARCHIMEDlife, and CENTOGENE N.V.



Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support


This product will be delivered within 2 business days.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Ahlstrom-Munksjö
  • ARCHIMEDlife
  • CENTOGENE N.V
  • F. Hoffmann-La Roche Ltd
  • PerkinElmer
  • QIAGEN

1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study
2 RESEARCH METHODOLOGY3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Use of DBS Cards in Diagnostic Testing
4.2.2 Rise of Forensic Toxicology Applications
4.3 Market Restraints
4.3.1 Contamination Caused in DBS Collection Cards
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Card Type
5.1.1 Ahlstrom 226
5.1.2 Whatman 903
5.1.3 FTA
5.1.4 Others
5.2 By Application
5.2.1 Infectious Disease Testing
5.2.2 Newborn Screening
5.2.3 Forensics
5.2.4 Therapeutic Drug Monitoring
5.2.5 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 F. Hoffmann-La Roche Ltd
6.1.2 QIAGEN
6.1.3 Shimadzu Scientific Instruments
6.1.4 Eastern Business Forms, Inc
6.1.5 Ahlstrom-Munksjö
6.1.6 PerkinElmer
6.1.7 ARCHIMEDlife
6.1.8 CENTOGENE N.V
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • F. Hoffmann-La Roche Ltd
  • QIAGEN
  • Shimadzu Scientific Instruments
  • Eastern Business Forms, Inc
  • Ahlstrom-Munksjö
  • PerkinElmer
  • ARCHIMEDlife
  • CENTOGENE N.V
Note: Product cover images may vary from those shown

Loading
LOADING...